I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
4.960
+0.720 (16.98%)
Aug 14, 2025, 11:40 AM - Market open
I-Mab Market Cap
I-Mab has a market cap or net worth of $570.37 million as of August 14, 2025. Its market cap has increased by 419.68% in one year.
Market Cap
570.37M
Enterprise Value
322.64M
1-Year Change
419.68%
Ranking
Category
Stock Price
$4.96
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has increased from $138.05M to $570.37M, an increase of 313.17%. That is a compound annual growth rate of 28.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 487.57M | 604.39% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |